4//SEC Filing
PENDARVIS DAVID 4
Accession 0001127602-23-000789
CIK 0000943819other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 12:54 PM ET
Size
4.3 KB
Accession
0001127602-23-000789
Insider Transaction Report
Form 4
RESMED INCRMD
PENDARVIS DAVID
Sr. VP, General Counsel
Transactions
- Sale
ResMed Common Stock
2023-01-03$210.07/sh−1,500$315,105→ 97,172 total
Footnotes (1)
- [F1]The transaction was conducted under a Rule 10b5-1 plan.
Documents
Issuer
RESMED INC
CIK 0000943819
Entity typeother
Related Parties
1- filerCIK 0001196723
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 12:54 PM ET
- Size
- 4.3 KB